Doctor of Optometry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Glen Lojka

Optometrist Ellisville, MO Doctor of Optometry

NPI 1912903907 CMS profile 358915

194 Clarkson Rd, Ellisville, MO 63011

Open in the dashboard

General payments

$44,592

568 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Glen Lojka of Ellisville, MO is reported in the CMS Open Payments database as having received $44,592 across 568 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Optometrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $5,216 67
2024 General $8,967 90
2023 General $6,452 86
2022 General $7,686 77
2021 General $9,021 116
2020 General $1,820 54
2019 General $5,430 78

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Glen Lojka
  • Optometrist median
  • Middle half of Optometrist
  • National median

In program year 2025, general payments to Glen Lojka were reported at $5,216. Among 35,373 Optometrist profiles paid that year, the median was $204 and the middle half received between $87 and $464.

Show as a table
Year Glen Lojka Optometrist median Middle half National median
2019 $5,430 $159 $67–$371 $163
2020 $1,820 $72 $29–$165 $114
2021 $9,021 $125 $46–$292 $132
2022 $7,686 $162 $66–$374 $149
2023 $6,452 $177 $72–$406 $160
2024 $8,967 $188 $77–$427 $164
2025 $5,216 $204 $87–$464 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. CooperVision Inc. $6,780 107 payments
  2. Sun Pharmaceutical Industries Inc. $5,679 18 payments
  3. AbbVie, Inc. $4,949 52 payments
  4. Alcon Vision LLC $4,570 70 payments
  5. Bausch & Lomb Americas Inc. $3,566 52 payments
  6. Allergan Inc. $3,426 70 payments
  7. Optos, Inc. $2,974 22 payments
  8. Eyevance Pharmaceuticals LLC $2,481 4 payments
  9. Sight Sciences, Inc. $1,954 36 payments
  10. Glaukos Corporation $1,914 10 payments
  11. Other $6,299 127 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $29,349 533 payments
  2. Consulting Fee $5,000 7 payments
  3. Honoraria $4,200 3 payments
  4. Entertainment $2,293 18 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2,100 1 payment
  6. Travel and Lodging $1,650 6 payments
Products named General payments · program years 2019–2025
  1. Cequa $5,657 17 payments
  2. MyDay Contact Lens $3,237 49 payments
  3. OCT OPHTHALMOSCOPE Ophthalmology $2,974 22 payments
  4. PANORAMIC OPHTHALMOSCOPE Ophthalmology $2,974 22 payments
  5. PANORAMIC OPHTHALMOSCOPE Ophthalmology $2,974 22 payments
  6. Zerviate $2,333 3 payments
  7. OCT OPHTHALMOSCOPE Ophthalmology $2,293 18 payments
  8. NFC-700 $2,293 18 payments
  9. INFUSE $2,257 44 payments
  10. CVI Contact Lens $1,579 14 payments
  11. Other $19,666 422 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

568 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record